1. Prexton Therapeutics SA; 1228 Plan-les-Ouates, Geneva Switzerland
2. Neuroscience Research Unit CHU de Québec, CHUL Pavillon and Faculty of Pharmacy; Laval University; Quebec City Quebec Canada
3. Motac Neuroscience Ltd; Manchester United Kingdom
4. Karolinska Institutet, Centre for Psychiatry Research, Department of Clinical Neuroscience; Stockholm Sweden